1-7 of 7
GF Gjerset
Close
Sort by
Journal Articles

Randomized study of didanosine monotherapy and combination therapy with zidovudine in hemophilic and nonhemophilic subjects with asymptomatic human immunodeficiency virus-1 infection. AIDS Clinical Trial Groups

MV Ragni, DA Amato, ML LoFaro, V DeGruttola, C Van Der Horst, ME Eyster, CM Kessler, GF Gjerset, M Ho, DM Parenti
Journal: Blood
Blood (1995) 85 (9): 2337–2346.
https://doi.org/10.1182/blood.V85.9.2337.bloodjournal8592337
Published: 1995
Journal Articles

Effect of low- and intermediate-purity clotting factor therapy on progression of human immunodeficiency virus infection in congenital clotting disorders. Transfusion Safety Study Group

GF Gjerset, MC Pike, JW Mosley, J Hassett, MA Fletcher, E Donegan, JW Parker, RB Counts, Y Zhou, CK Kasper
Journal: Blood
Blood (1994) 84 (5): 1666–1671.
https://doi.org/10.1182/blood.V84.5.1666.1666
Published: 1994
Journal Articles

Effect on lymphocyte subsets of clotting factor therapy in human immunodeficiency virus-1-negative congenital clotting disorders. The Transfusion Safety Study Group

J Hassett, GF Gjerset, JW Mosley, MA Fletcher, E Donegan, JW Parker, RB Counts, LM Aledort, H Lee, MC Pike
Journal: Blood
Blood (1993) 82 (4): 1351–1357.
https://doi.org/10.1182/blood.V82.4.1351.1351
Published: 1993
Journal Articles

Effect of age on human immunodeficiency virus type 1-induced changes in lymphocyte populations among persons with congenital clotting disorders. Transfusion Safety Study Group

MA Fletcher, JW Mosley, J Hassett, GF Gjerset, J Kaplan, JW Parker, E Donegan, JM Lusher, H Lee
Journal: Blood
Blood (1992) 80 (3): 831–840.
https://doi.org/10.1182/blood.V80.3.831.831
Published: 1992
Journal Articles

Treatment type and amount influenced human immunodeficiency virus seroprevalence of patients with congenital bleeding disorders

GF Gjerset, MJ Clements, RB Counts, AS Halvorsen, AR Thompson
Journal: Blood
Blood (1991) 78 (6): 1623–1627.
https://doi.org/10.1182/blood.V78.6.1623.1623
Published: 1991
Journal Articles

Lymphadenopathy-associated virus antibodies and T cells in hemophiliacs treated with cryoprecipitate or concentrate

GF Gjerset, G McGrady, RB Counts, PJ Martin, J Jason, S Kennedy, B Evatt, JA Hansen
Journal: Blood
Blood (1985) 66 (3): 718–720.
https://doi.org/10.1182/blood.V66.3.718.718
Published: 1985
Journal Articles

Immunologic status of hemophilia patients treated with cryoprecipitate or lyophilized concentrate

GF Gjerset, PJ Martin, RB Counts, LD Fast, JA Hansen
Journal: Blood
Blood (1984) 64 (3): 715–720.
https://doi.org/10.1182/blood.V64.3.715.715
Published: 1984